The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin

Fontana, Pierre; Alberts, P; Sakariassen, K S; Bounameaux, Henri; Meyer, J-P; Santana Sorensen, A

doi:10.1111/j.1538-7836.2011.04446.x

Scientific article

Letter

English

The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin

ContributorsFontana, Pierre; Alberts, P; Sakariassen, K S; Bounameaux, Henri; Meyer, J-P; Santana Sorensen, A

Published inJournal of thrombosis and haemostasis, vol. 9, no. 10, p. 2109-2111

Publication date2011

Keywords

Aspirin/pharmacology
Enzyme Inhibitors/pharmacology
Humans
Platelet Aggregation Inhibitors/pharmacology
Receptors, Thromboxane/antagonists & inhibitors
Thromboxane-A Synthase/antagonists & inhibitors

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Geneva Platelet Group (13)

Citation (ISO format)

FONTANA, Pierre et al. The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin. In: Journal of thrombosis and haemostasis, 2011, vol. 9, n° 10, p. 2109–2111. doi: 10.1111/j.1538-7836.2011.04446.x

Article (Published version)

Identifiers

PID : unige:23987
DOI : 10.1111/j.1538-7836.2011.04446.x
PMID : 21777369

Journal ISSN1538-7836

512views

0downloads

Creation10/11/2012 8:53:00 AM

First validation10/11/2012 8:53:00 AM

Update time03/14/2023 5:44:57 PM

Status update03/14/2023 5:44:56 PM

Last indexation10/30/2024 7:52:30 AM

Archive ouverte UNIGE

The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin

Technical informations